- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05823038
Risk and Aesthetic Assesment in Implant Patient (EIPPDRAAS)
Evaluation of Implant Patients by Peri-implant Disease Risk Analysis and Aesthetic Score
This study examines the peri-implant risk assessment diagram and the aesthetic, peri-implant health status, and gingival level around the implant in patients with implants by comparing them in smokers and non-smokers.
: After completion of the examination, 298 dental implants for at least three months after functional prosthesis loading, except for patients with bruxism and uncontrolled diabetes, were included in the study. Patients are primarily divided into smokers and non-smokers. In all implant patients, plaque, gingival index, bleeding on probing, pocket depth, clinical attachment loss, gingival recession, keratinized thickness, keratinized width, vestibule depth, pink aesthetic score, and peri-implant disease risk analysis are evaluated in sequence.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Bolu, Turkey
- Bolu abant Izzet Baysal University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- 18-70 years old patients
- Patients who are systemically healthy and have a controlled medical condition
- Patients with fixed prosthesis on the implant at least 6 months after the functional prosthetic loading of the dental implant
Exclusion Criteria:
- Patients with uncontrolled systemic diseases
- Those who have the habit of bruxism
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Keratinized tissue thickness
Time Frame: baseline
|
It is advanced to the bone with a canal file.
The distance between the stopper and the tip of the file is measured.
|
baseline
|
|
Keratinized tissue width
Time Frame: baseline
|
Keratinized mucosa width was defined as the distance between the gingival margin and mucogingival junction at the mid-buccal area
|
baseline
|
|
Periodontal depth
Time Frame: baseline
|
Measuring the distance from the gingival margin to the mucogingival line with a periodontal probe.
|
baseline
|
|
Bleeding on probing
Time Frame: baseline
|
To determine the bleeding index on probing, the pocket floor, and the inflammatory state of the pocket epithelium, an evaluation is made according to whether there is bleeding in the sulcus 30 seconds after the pocket depth measurement from 6 regions of all the teeth of the patients: mesiobuccal, mid-buccal, distobuccal, mesiolingual, mid-lingual and distolingual.
|
baseline
|
|
Vestibular depth
Time Frame: baseline
|
Vestibular depth is measured either from crest of lip or from coronal border of the attached gingiva to depth of mucobuccal fold.
|
baseline
|
|
Implant disease risk assesment
Time Frame: baseline
|
The IDRA algorithm is a promising tool to assess patients at moderate or high risk of developing peri-implantitis.
The eight vectors of the diagram include: an assessment of a history of periodontitis, the percentage of sites with bleeding on probing (BOP), the number of teeth/implants with probing depths (PD) ≥5 mm, the ratio of periodontal bone loss (evaluated from a radiograph) divided by the patient's age, periodontitis susceptibility as described by the staging and grading categories from the 2017 World Workshop on the Classification of Periodontal and Peri-implant Diseases , the frequency/compliance with supportive periodontal therapy, the distance from the restorative margin of the implant-supported prosthesis to the marginal bone crest, and prosthesis related factors including cleanability and fit of the implant-supported prosthesis.
|
baseline
|
|
Pink esthetic scale
Time Frame: baseline
|
With the pink aesthetic score, the post-implant process is scored according to the papilla, tissue contours, gingival level, alveolar process, color, and tissue condition.
The thresholds for clinical acceptance, which was currently set at values of 8/14 for the PES.
The thresholds for clinical acceptance are currently set at values of 8 to 14 for the PES.
|
baseline
|
|
Dental implant health scale
Time Frame: baseline
|
The Implant Quality of The Health Scale allows the dentist to evaluate an implant using the listed criteria, place it in the appropriate category of health or disease, and then treat the implant accordingly. Three primary classes were established by the Consensus: success, survival, and failure. The success category describes optimum conditions, the survival category describes implants still in function but not with ideal conditions, and the loss of an implant represents an the implant that should be or already has been removed. Implant Quality Scale Group Clinical Conditions
|
baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Plaque index
Time Frame: baseline
|
In the plaque index, the mesiobuccal, mid-buccal, distobuccal, mesiolingual, mid-lingual, and distolingual regions of the implant or implants and dental plaque thickness to the gingiva are evaluated by probing.
|
baseline
|
|
Gingival index
Time Frame: baseline
|
The gingival index evaluates bleeding, the most basic sign of inflammation.
The implants' mesiobuccal, mid-buccal, distobuccal, mesiolingual, mid-lingual, and distolingual surfaces are measured.
|
baseline
|
|
Clinical attachment level
Time Frame: baseline
|
Clinical attachment level/loss measured in mm as distance from the CEJ to the gingival margin.
|
baseline
|
|
Gingival recession
Time Frame: baseline
|
Gingival recession is the exposure of the root surface resulting from migration of the gingival margin apical to the cementoenamel junction.
|
baseline
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ramazan Kurul, Ass. Prof, Abant Izzet Baysal University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2022/160
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Implant Assesment
-
Gulf Medical UniversityCompletedImplant AssesmentEgypt
-
Mansoura UniversityActive, not recruiting
-
Mansoura UniversityActive, not recruitingCompletely Edentulous | Implant AssesmentEgypt
-
Mansoura UniversityActive, not recruitingVitamin D Deficiency | Radiography | Clinical and Radiographic Effect | Implant AssesmentEgypt
-
Hager Montaser Sayed BedeerNot yet recruitingBack Rolls Assesment | Back Rolls Management
-
Cairo UniversityNot yet recruitingCaries Risk Assesment
-
Hacettepe UniversityCompletedCardiac Surgery | Drug Related Problems | Clinical Pharmacy | Risk AssesmentTurkey
-
National Institute of Cardiovascular Diseases,...RecruitingCardiovascular Morbidity | Cardiovascular Risk Assesment | Primary Prevention CVDPakistan
-
Ain Shams UniversityAugusta UniversityNot yet recruitingImplant Primary Stability | Implant Osseointegration | Immediate Implant Placement | Implant Placement | Implant Osteotomy | Molar Extraction SocketEgypt
-
Vilniaus Implantologijos Centro (VIC) KlinikaInstitut Straumann AGActive, not recruitingSingle Implant; Immediate Implant Treatment; Early Implant TreatmentLithuania